For laboratory research use only · Not for human or veterinary use · 18+

How Long Does Retatrutide Last Once Mixed With Bacteriostatic Water?

Storage · 7 min read · Updated 30 September 2026

Retatrutide mixed with bacteriostatic water is generally held in a 2 to 8 °C refrigerator, where laboratories consume it within about 28 days, the in-use limit conventionally applied to a preserved multi-draw stock. No published stability study defines an exact shelf life for research-grade retatrutide in solution, so the 28 day figure is a working convention rather than a tested expiry. Sealed lyophilised powder held at -20 °C remains stable far longer.

Macropus Peptides supplies the freeze-dried peptide in Retatrutide 10mg, 15mg, 20mg and 30mg research vials, and the product page is where laboratories order it. The sections that follow address what happens to the molecule once diluent is added, and how storage conditions protect the integrity of experimental data.

Why Is 28 Days the Usual Limit for Mixed Retatrutide?

The 28 day limit comes from the in-use period applied to opened multi-use containers of preserved water, not from degradation data specific to retatrutide. Chemically, the peptide is resilient. Its 39 amino acid chain includes non-natural residues such as alpha-aminoisobutyric acid that resist proteolysis, and a C20 fatty diacid that binds albumin. Those features were engineered for stability in plasma, and they also help in a vial.

The limiting factor is microbiological. A reconstituted research vial is punctured repeatedly, and every puncture is an opportunity for contamination. Bacteriostatic water carries benzyl alcohol as its preservative, and that 9 mg per mL concentration suppresses bacterial growth, but it does not sterilise a contaminated vial. Most protocols therefore set 28 days at 2 to 8 °C as the ceiling, and many adopt a shorter window where reproducibility requirements are tight.

How Long Does Retatrutide Last Once Mixed or Sealed: Storage Timeline

FormTemperatureWorking limitNotes
Unopened powder, freezer-20 °CLong term, to the certificate datePreferred for vials not needed this month
Unopened powder, refrigerator2 to 8 °CSeveral weeksSuitable for vials due to be mixed soon
Unopened powder, in transitAmbientDaysLyophilised powder tolerates shipping
Reconstituted with bacteriostatic water2 to 8 °CAbout 28 daysLabel with date and mg per mL
Reconstituted with sterile water2 to 8 °COne sessionNo preservative, discard after use
Reconstituted solution on the benchRoom temperatureHours onlyReturn to refrigeration promptly
Reconstituted solution frozenUnder 0 °CNot recommendedAggregation risk on thawing
Pre-filled penAs labelledSee the pen cartonSupplied already in solution

The limits assume aseptic technique and a vial kept upright in its carton, away from light.

Does Retatrutide Need to Be Refrigerated?

Reconstituted retatrutide does need to be refrigerated, and the vial should return to 2 to 8 °C immediately after every draw. Heat accelerates the slow degradation reactions that affect peptides in solution, including oxidation, deamidation of glutamine residues and isomerisation at aspartate, and it shortens the lag before any contaminating organism begins to grow.

Lyophilised powder is considerably more tolerant. With almost no water present, molecular mobility is minimal, which is why sealed vials come through a few days of courier transit unaffected. For anything beyond short-term holding, however, -20 °C is preferable to the refrigerator.

Refrigerator placement

Store vials on a middle shelf rather than in the door, where temperature fluctuates each time it opens. Avoid the rear wall of compact refrigerators, where contents can freeze. A min and max thermometer kept beside the vials confirms that the 2 to 8 °C range is actually being held.

How Long Does Retatrutide Last in the Fridge?

Unmixed retatrutide in a sealed vial lasts for several weeks in the fridge, while mixed retatrutide in bacteriostatic water is used within about 28 days. The chemistry of the dry cake is the constraint for the first case and the in-use convention for the second. Laboratories that do not expect to reconstitute a vial within a few weeks should move it to -20 °C instead, where the certificate date applies.

Which Vial Size Suits a 28 Day Window?

The right vial size is the one a study will consume within 28 days of reconstitution, because unused solution past that point is normally discarded. A 10mg vial reconstituted in 2 mL gives 5 mg per mL; a 30mg vial in 3 mL gives 10 mg per mL. If a protocol draws only small volumes, a larger vial may still be in refrigerated storage when the window closes, so match vial size to the rate of use rather than to the lowest cost per milligram.

VialConcentrationDiluent addedPer unit on a U-100 syringe
10mg5 mg per mL2 mL50 mcg
15mg5 mg per mL3 mL50 mcg
20mg10 mg per mL2 mL100 mcg
30mg10 mg per mL3 mL100 mcg

The same arithmetic for any diluent volume is available in our peptide concentration calculator.

Can Reconstituted Retatrutide Be Used After Freezing?

Reconstituted retatrutide that has frozen should not be used for research data without reanalysis, because freezing can aggregate the peptide in ways that thawing does not reverse. As a solution freezes, water crystallises first and the dissolved peptide and salts are concentrated into shrinking pockets of liquid. Under those conditions chains can associate, and the fatty diacid on retatrutide makes it more prone to self-association than an unmodified peptide. A thawed solution can appear perfectly clear and still contain less monomeric peptide than the label states.

A vial frozen accidentally should be discarded, or a sample reassayed by HPLC before any data it produces is accepted. Planned freezing is a separate practice: some groups portion freshly reconstituted retatrutide into single-draw aliquots within hours of mixing and freeze each portion once, never refreezing a thawed aliquot. That approach requires validation within the laboratory's own methods.

Should Laboratories Choose Vials or Pens for Storage?

Laboratories with irregular schedules generally choose lyophilised vials, because a vial's in-use clock starts only when diluent is added. The Retatrutide pen, available in 15mg, 20mg, 30mg and 70mg formats, is supplied with the peptide already in solution, so its storage conditions are those printed on the carton. Whichever format is chosen, keep an unopened bottle of bacteriostatic water for peptide reconstitution in stock, because an opened diluent bottle is subject to a 28 day limit of its own. The complete metabolic research range follows the same storage conventions.

Laboratory Storage Routine

  • Record the lot number and date of receipt for every vial
  • Hold sealed vials at -20 °C until the week they are required
  • Mark each reconstituted vial with the date, diluent volume and mg per mL
  • Keep reconstituted vials standing in their cartons in the 2 to 8 °C refrigerator
  • Swab the stopper before each draw and use a new sterile syringe every time
  • Discard at 28 days, or earlier if the solution becomes cloudy or shows particles

Our recommendation is to reconstitute only as much retatrutide as the study will use within four weeks and to keep the remainder frozen and dry. When a laboratory is ready to order, the Retatrutide research vial range lists every available size. For a comparison of the molecule with tirzepatide and semaglutide, read retatrutide vs semaglutide vs tirzepatide.

Questions about how long does retatrutide last once mixed

Products in this article

HPLC · CoA
Retatrutide 10mg research peptide vial
Research use only · Not for human consumption
MACROPUSPEPTIDES
Retatrutide
10 MG
Lyophilised powder · Store -20 °C
Lot [ ]Exp [ ]
Metabolic research
4 strengths, 10mg to 30mg
From $159.99
CoA
BAC Water Bacteriostatic 3mL vial
Research use only · Not for human consumption
MACROPUSPEPTIDES
BAC Water
Bacteriostatic
3 ML
Laboratory supply
Lot [ ]Exp [ ]
Lab supplies
Sterile vial, 3mL
$12.99
HPLC · CoA
Retatrutide pen 15mg pre-filled research pen
Metabolic research
4 strengths, 15mg to 70mg
From $229.99
Browse the full research peptide range
Sources
  1. LY3437943, a novel triple GIP, GLP-1 and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised trial. The Lancet. 2022.

Written by the Macropus Peptides technical team for in-vitro laboratory research reference. Not medical advice; products are not for human or veterinary use and are sold to buyers aged 18 and over.

Chat on WhatsApp